Amvuttra 25 mg/0.5 mL prefilled syringe Images
Generic Name: vutrisiran
This medication has been identified as Amvuttra 25 mg/0.5 mL prefilled syringe and is used for Hereditary Amyloidosis, Cardiomyopathy of Transthyretin-Mediated Amyloidosis, and Transthyretin-Related Amyloidosis. It belongs to the drug class miscellaneous metabolic agents and is not a controlled substance.
Images of medication
Amvuttra
- Generic Name
- vutrisiran
- Strength
- 25 mg/0.5 mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alnylam Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71336-1003
See also:
More about Amvuttra (vutrisiran)
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.